(MENAFN- EIN Presswire)
Emergen Research Logo
Global Anti-Diuretic Drugs Market: Driving Factors, Challenges, and Growth Trends
VANCOUVER, BC, CANADA, June 3, 2024 /EINPresswire / -- The anti-diuretic drugs market size reached USD 494.13 Million in 2023 and is expected to register a revenue CAGR of 13.4% during the forecast period. The global market for anti-diuretic drugs is experiencing steady growth, driven by several key factors. According to a recent report, the market is expected to continue its upward trajectory, fueled by rising cases of diabetes insipidus, advancements in medical technology, and increasing product launches.
Market Drivers
Rising Diabetes Cases: With a significant increase in global diabetes instances, the demand for anti-diuretic drugs is on the rise. The International Diabetes Federation (IDF) estimates a substantial surge in diabetes cases by 2045, further driving the demand for these medications.
Product Upgrades: Major market players are continuously upgrading their product portfolios, enhancing treatment options and driving market growth. Recent approvals, such as Amphastar Pharmaceuticals' Vasopressin injection by the U.S. FDA, signify this trend.
Use of Desmopressin Analogs: The growing utilization of desmopressin analogs, known for their efficacy in managing diabetes insipidus, is contributing to market expansion. These analogs offer various formulations, increasing their acceptance among end-users.
Rising Geriatric Population: The increasing prevalence of diabetes insipidus among the elderly, coupled with the expanding geriatric population globally, is driving market growth. Improvements in healthcare and a longer life expectancy contribute to the rise in urologic conditions, necessitating anti-diuretic drug treatment.
Explore Every Detail: Download the Sample Report Here @
Market Restraints
Despite the positive outlook, the market faces challenges. Health complications associated with vasopressin use, such as asthma and heart disease, erode patient trust and hinder market growth. Skepticism surrounding vasopressin treatment leads to reluctance among patients, impacting market performance.
Market Segment Insights
Type Dynamics: The market is segmented into oxytocin, vasopressin, and desmopressin. Vasopressin dominates the market due to its essential role in renal function, while desmopressin shows robust growth with increased efficacy and fewer side effects.
Application Insights: Diabetes insipidus holds the largest revenue share, driven by the clinical need for effective treatment options.
Distribution Channel Insights: Hospital pharmacies lead in revenue share, attributed to increased admissions for urological illnesses. Online pharmacies show robust growth, supported by factors like internet penetration and home delivery services.
Anti-Diuretic Drugs Top Companies and Competitive Landscape
The global anti-diuretic drugs market is fairly fragmented, with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective solutions.
Par Sterile Products, LLC.
Pfizer Inc.
ADH Health
Otsuka Holdings Co., Ltd.
Azevan Pharmaceuticals, Inc.
Taj Pharmaceuticals Limited.
Endo International
Ferring Pharmaceuticals
Fresenius Kabi.
Hybio Pharmaceutical.
Hainan Zhonghe Pharmaceutical.
Avadel
Hoffman-La Roche Ltd
CSL Limited.
Bayer
Eisai Co., Ltd.
Allergan
Sanofi S.A
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Other companies
Your next big opportunity is just a purchase away – buy the report now @
Anti-Diuretic Drugs Latest Industry Updates
On February 2022, Dr. Reddy's Laboratories announced the launch of its authorized generic version of VASOSTRICT (vasopressin injection, USP) vials U.S. Market, to expand their geographical across U.S. The product is approved by the U.S. Food and Drug Administration (USFDA).
On February 25, 2020, Lupin announced the launch of Ethacrynic Acid Tablets USP, 25 mg, after the receiving approval from United States Food and Drug Administration (U.S. FDA)
Anti-Diuretic Drugs Market Segment Analysis
For the purpose of this report, Emergen Research has segmented global anti-diuretic drugs market on the basis of Type, Application, Distribution Channel, and region:
Type Outlook (Revenue, USD Million; 2020-2033)
Oxytocin
Vasopressin
Desmopressin
Application Outlook (Revenue, USD Million; 2020-2033)
Diabetes Insipidus
Hemophilia
Hypertension
Others
Distribution Channel Outlook (Revenue, USD Million; 2020-2033)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Regional Outlook (Revenue, USD Million; 2020-2033)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Deepen Your Understanding: Click Here for the Full Report @
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Eric Lee
Emergen Research
+91 90210 91709
...
Visit us on social media:
Facebook
X
LinkedIn
MENAFN03062024003118003196ID1108290688
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.